Microemulsion-based hydrogel formulation for transdermal delivery of dexamethasone
Main Article Content
to the skin. The pharmacodynamic studies indicated that microemulsion based on nutmeg oil demonstrated a significantly
(P < 0.05) higher anti-inflammatory potential. The nutmeg oil-based transdermal microemulsion gel system demonstrated
73.6% inhibition in rat paw edema. Thus, microemulsion-based transdermal systems are a promising formulation for dermal
delivery of dexamethasone.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
Tenjarla S. Microemulsions: An overview and pharmaceutical
applications. Crit Rev Ther Drug Carrier Syst 1999;16:461-521.
Lawrence MJ, Rees GD. Microemulsion-based media as novel drug
delivery systems. Adv Drug Deliv Rev 2000;45:89-121.
Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A.
Microemulsions for dermal delivery of estradiol. Int J Pharm
Sintov AC, Shapiro L. New microemulsion vehicle facilitates
percutaneous penetration in vitro and cutaneous drug bioavailability
in vivo. J Control Rel 2004;95:173-83.
Lapasin R, Grassi M, Coceani N. Effects of polymer addition on the
rheology of o/w microemulsions. Rheol Acta 2001;40:185-92.
Spiclin P, Homar M, Zupancic-Valant A. Sodium ascorbyl phosphate in
dermal microemulsions. Int J Pharm 2003;256:65-73.
Valenta C, Schultz K. Influence of carrageenan on the rheology
and skin permeation of microemulsion formulations. J Control Rel
Gulsen D. Chauhan A. Dispersion of microemulsion drops in HEMA
hydrogel: a potential ophthalmic drug delivery vehicle. Int J Pharm
Reynolds JE, editor. Martindale: The Extra Pharmacopoeia. London:
Royal Pharmaceutical Society; 1996. p. 1042-5.
Kobayashi I, Hosaka K, Maruo H, Saeki Y, Kamiyama M, Konno C,
et al. Role of prostaglandin E2 and leukotriene B4 in skin reaction
induced by transdermal application of propanolol. Biol Pharm Bull
Slayden SM, Crabbe L, Bae S, Potter HD, Azziz R, Parker CR Jr. Effect
of 17Î²-estradiol on adrenocortical sensitivity responsiveness and
steroidogenesis in postmenopausal women. J Clin Endocrinol Metab
Fischer DK, Simpson RK Jr, Smith FA Jr, Mattox KL. Efficacy of
dexamethasone in benzodiapine resistant delirium tremens. Lancet
Heath D, Williams DR. High Altitude Medicine and Pathology. Oxford:
Oxford University Press; 1995. p. 3-29.
Mantovani G, Curreli L, Maccio A, Massa E, Massa D, Mulas C, et al.
Prevention of nausea and vomiting (N and V) in cancer patients receiving
high-dose cisplatin Assessment of the potential antiemetic activity of
trandermal fentanyl (TTS-F) compared to standard antiemetic treatment
in acute and delayed N and V: First clinical report. Anticancer Res
Nagashima M, Wauke K, Hirano D, Ishigami S, Aono H, Takai M, et al.
Effects of combinations of anti-rheumatic drugs on the production of
vascular endothelial growth factor and basic fibroblast growth factor
in cultured synoviocytes and patients with rheumatoid arthritis.
Rheumatology (Oxford) 2000;39:1255-62.
Tsuei SE, Moore RG, Ashley JJ, McBride WG. Disposition of synthetic
glucocorticoids I Pharmacokinetics of dexamethasone in healthy adults.
J Pharmacokin Biopharm 1979;7:249-64.
Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable
drug carriers have increased biological potency, prolonged effect, and
reduced therapeutic dosage. Biochim Biophys Acta 2004;1663:61-73.
Jain S, Jain P, Umamaheshwari RB, Jain NK. Transfersomes - a novel
vesicular carrier for enhanced transdermal delivery: Development,
characterization, and performance evaluation. Drug Dev Ind Pharm
Mukherjee B, Mahapatra S, Gupta R, Patra B, Tiwari A, Arora P.
A comparison between povidone-ethylcellulose and povidone-eudragit
transdermal dexamethasone matrix patches based on in vitro skin
permeation. Eur J Pharm Biopharm 2005;59:475-83.
Gonyer D, Heck M. Transdermal delivery of dexamethasone and
promethazine. US patent no. 2008/0241231.
Thioune O, Ahodikpe D, Dieng M, Diop AB, Ngom S, Lo I. Inflammatory
ointment from shea butter and hydro-alcoholic extract of Khaya
senegalensis barks (Cailcederat). Dakar Med 2000;45:113-6.
Fialho SL, da Silva-Cunha A. New vehicle based on a microemulsion for
topical ocular administration of dexamethasone. Clin Exp Ophthalmol
Banta CA. A prospective randomized study of iontophoresis wrist
splinting and anti-inflammatory medication in the treatment of
earlymild carpal tunnel syndrome. J Occup Med 1994;36:166-8.
Cabello Benavente R, Moncada Iribarren I, de Palacio EspaÃ±a A,
HernÃ¡ndez Villaverde A, MonzÃ³ JI, HernÃ¡ndez FernÃ¡ndez C. Transdermal
iontophoresis with dexamethasone and verapamil for Peyronieâ€™s
disease. Actas Urol Esp 2005;29:955-60.
Di Stasi SM, Giannantoni A, Capelli G, Jannini EA, Virgili G, Storti L,
et al. Transdermal electromotive administration of verapamil and
dexamethasone for Peyronieâ€™s disease. BJU Int 2003;91:825-9.
Byl NN, McKenzie A, Halliday B, Wong T, Oâ€™Connell J. The effects of
phonophoresis with corticosteroids: A controlled pilot study. J Orthop
Sports Phys Ther 1993;18:599-600.
Johnson ME, Mitragotri S, Patel A, Blankschtein D, Langer R. Synergistic
effects of chemical enhancers and therapeutic ultrasound on
transdermal drug delivery. J Pharm Sci 1996;85:670-9.
Drazie J. Appraisal of the safety and chemical in foods drugs and
cosmetics by the Staff of the Division of Pharmacology Food and Drug
Administration Department of Health Education and Welfare, Topeka,
KS: FDA Officials of US Business Office; 1959. p. 46.
Alol A, Kuriyana K, Shimiza T, Yoshioka M. Effects of vitamin E and
squalene on skin irritation of a transdermal absorption enhancer lauryl
sacrosine. Int J Pharm 1993;93:1-6.
Vandamme TF. Microemulsions as ocular drug delivery systems:
Recent developments and future challenges. Prog Retinal Eye Res
Chen H, Chang X, Weng T, Zhao X, Gao Z, Yang Y, et al. A study of
microemulsion systems for transdermal delivery of triptolide. J Control